Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Blood Screening Assay Approved in China and Brazil

By LabMedica International staff writers
Posted on 18 Nov 2010
An assay used in markets around the globe to screen donated blood for human immunodeficiency virus (HIV) Type 1 and Hepatitis viruses types B and C, has been granted approval for use in China and Brazil.

Sensitivity combined with the fully integrated and automated Procleix Ultrio assay, which is run on the TIGRIS platform, simplifies workflow and improves efficiency in the lab, a critical component to ensure testing and results are completed on time.

Novartis Diagnostics (Basel, Switzerland) launched the Procleix Ultrio assay and the Procleix TIGRIS platform in China at the Chinese Society of Blood Transfusion (CSBT) meeting, which took place on November 4-6, 2010, in Chengdu, China. More...
In Brazil, Novartis featured the Procleix Ultrio assay and the Procleix TIGRIS platform during the HEMO-Brazil meeting, which took place November 5-8, 2010, in Brasilia.

The company is working closely with blood centers in China and Brazil to introduce Ultrio and TIGRIS and help add an additional layer of blood safety to the blood screening process. In China, Novartis Diagnostics is collaborating with the Ministry of Health as part of the 2010 China nucleic acid testing (NAT) pilot program, sharing knowledge and best practices with blood centers using the Procleix Ultrio and TIGRIS systems to test NAT in their blood centers.

Blood screening centers in China and Brazil currently receive 10 million and 4.3 million annual blood donations, respectively. Blood centers in both countries are incorporating additional layers of protection to the blood screening process to increase the safety of the blood supply from donor to patient.

Related Links:

Novartis Diagnostics





Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.